Curanex Pharmaceuticals (CURX) Other Non Operating Income (2024 - 2025)
Curanex Pharmaceuticals' (CURX) quarterly Other Non Operating Income came in at $19521.0 in Q4 2025, up 1267.97% YoY from $1427.0 in Q4 2024, and up 1337.48% on a QoQ basis from $1358.0 in Q3 2025.
Curanex Pharmaceuticals (CURX) Other Non Operating Income (2024 - 2025) Analysis & Trends
Curanex Pharmaceuticals (CURX) has 2 years of Other Non Operating Income data on file, last reported at $19521.0 in Q4 2025.
- Quarterly Other Non Operating Income rose 1267.97% year-over-year to $19521.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22709.0 (changed N/A YoY) and the FY2025 annual result came in at $22507.0, up 532.93% from the prior year.
- Other Non Operating Income advanced to $19521.0 in Q4 2025, from $1358.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $19521.0 in Q4 2025 to a low of $403.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curanex Pharmaceuticals | 6.02 Mn | 1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,521.00 |
| Sep 30, 2025 | 1,358.00 |
| Jun 30, 2025 | 403.00 |
| Dec 31, 2024 | 1,427.00 |
| Sep 30, 2024 | 2,129.00 |